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Introduction
Acute ischemic stroke is the most prevalent cerebrovascular disease in the world, accounting for 70%-80% of all stroke patients (Feigin et al., 2018; Hankey, 2017) . The prevalence of new cases worldwide reaches up to 10 million per year, and is currently on the rise. The incidence also significantly increased in younger populations (Roth et al., 2018; Wu et al., 2019) . Currently, early revascularization remains the most effective regimen, which includes intravenous thrombolysis with alteplase within 4.5 hours of onset and mechanical thrombectomy within 6 hours of onset (Kernan et al., 2014; Wang et al., 2017) . This treatment aims to reopen the occluded blood vessels, restore local blood perfusion, rescue dying cells in the ischemic penumbra, and improve the prognosis of patients. However, due to the limited time-window, it can only be applied on 3%-8.5% of patients with ischemic stroke.
The pathological mechanism of ischemic cerebral injury is complex, and many factors involved in this pathological process. The recovery process after ischemic stroke requires endogenous self-repair, including a series of complex processes such as cell viability maintenance, vascular and nerve regeneration, and synaptic and axonal growth (Sandvig et al., 2018; Zhang and Chopp, 2015) . Recent studies on the molecular mechanisms of ischemic cerebral injury showed that an impaired synaptic plasticity and the disappearance of synaptic activity are the earliest pathological changes associated with cerebral ischemia (Gonzalez, 2006; JA et al., 2014) . After the onset of focal cerebral ischemic injury, neuronal necrosis, and changes in synaptic regeneration, neuronal growth, and synaptic morphology often occur within a few hours and last for several days, and they are the main mechanisms that ultimately lead to neurological impairment, sensory and motor dysfunction. Therefore, developing new therapeutic strategies to promote the repair of synapses may shed light on neurological recovery post cerebral ischemia.
Cocaine-regulated and amphetamine-regulated transcript (CART) is a neuropeptide expressed by nerve ganglia and neuroendocrine tissues (Zhang et al., 2012) . It is widely expressed in brain tissue and is associated with various brain functions, including energy metabolism, appetite control, and neuroprotection (Ahmadian-Moghadam et al., 2018; Chang et al., 2011; Ivanusic et al., 2012; Rogge et al., 2008) . In recent years, many studies have found that CART was expressed in the cerebral cortex of rats with focal cerebral ischemia and in oxygen-glucose deprived cortical neurons cultured in vitro. It can reduce the volume of a cerebral infarct caused by middle cerebral artery occlusion (MCAO). In vitro applicatioin of CART on cerebral cortical neurons reduced oxygen-glucose deficiency induced neuronal cell death. After Knocking down of CART expression by shRNA, the ischemic cerebral infarct volume and the nerve cell mortality rate upon oxygen-glucose deprivation were both increased in mice (Sha et al., 2014; Sha et al., 2013; Xu et al., 2006) , suggesting that CART has protective effects on local ischemic J o u r n a l P r e -p r o o f nerve cells. In vitro studies have found that CART played a regulatory role by enhancing phosphorylation of extracellular signal-regulated kinase (ERK), affecting calcium channel activity (Jia et al., 2008) . CART expression was associated with dopamine levels and it protected against the ischemic cerebral injury by reducing inflammation activation (Lin et al., 2018) . Our preliminary study found that CART protects oxygen-deficient neurons by inhibiting oxidative stress and protecting mitochondrial function (Sha et al., 2013) . CART has reported neuroprotective effects; however, its mechanism of action has not yet been elucidated. Other studies have shown that CART can not only be expressed in the soma but also in the synapses of Purkinje fibroblasts in rat brain tissue (Ozcan et al., 2006) , and CART treatment can promote the formation of neural cell synaptic connections (Dun et al., 2002; Hubert and Kuhar, 2005; Sarkar et al., 2004) . A recent study has found that CART treatment can improve the memory and synaptic structure of APP/PS1 mice (Jin et al., 2015) . To date, the regulatory effect of CART on synaptic plasticity in ischemic cerebral injury has not been reported.
The objectives of the current study were to observe the effects of CART on the synaptic structure of oxygen-glucose deprivation (OGD) neurons and ischemic cortical neurons by using oxygen deprived neurons (in vitro) and ischemia-reperfusion cerebral ischemia (in vivo) models, and to investigate the mechanisms of CART in protecting the synaptic structures of ischemic neurons. We aimed to reveal the role and mechanism of CART in regulation of ischemia-induced synaptic plasticity injury, and to provide a new rationale for the development of CART as a therapeutic drug for ischemic stroke.
Results

CART protected against OGD-induced neurons injury in vitro
To verify the protective effect of CART 55-102 on OGD-induced neurons, primary cortical neurons were incubated with OGD and 0.4 nM (based on our preliminary data (Sha et al., 2013) ) of CART 55-102 . CCK-8 was used to determine the viability of the neurons in each group. As expected, the viability of the cortical neurons exposed to OGD was reduced by 52.19% in comparison with the normal group (p<0.01). However, CART 55-102 significantly enhanced neuronal viability in comparison with the OGD group (65.84±5.45% vs 47.81±1.71%, p<0.05). This result indicates that CART 55-102 elevates the survival rate of OGD-exposed neurons and verifies that CART inhibits OGD-induced neurotoxicity (Fig.1 ).
CART protected neurite and synapse structure in OGD cortical neurons and ischemia/reperfusion mice
To observe the effect of CART on the synaptic structure of OGD neurons, primary neuron culture was performed. CART 55-102 (0.4 nM) was added after the OGD treatment. A MAP2-specific antibody and a synaptophysin-specific antibody were used for immunofluorescence double staining. After staining, it was found that the J o u r n a l P r e -p r o o f growth of axons and dendrites in neurons was significantly inhibited and that synaptophysin was decreased. CART treatment reversed the inhibitory effect of OGD on synaptic growth of neurons and increased synaptophysin ( Fig.2A ). To further validate the protective effect of CART on synaptic structures following ischemic cerebral injury, we adopted a mouse model of ischemia/reperfusion (I/R). Transmission electron microscopy showed that the number of presynaptic vesicles in ischemic cortical neurons was significantly decreased, the synaptic structure was damaged and the postsynaptic density (PSD) was significantly decreased. CART treatment increased the number of presynaptic vesicles in neurons and increased PSD thickness, indicating that CART has protective effects on ischemia-induced synaptic damage in the cortical neurons of mice ( Fig.2B ). We also detected the expression of synaptophysin by western blot. The results showed that there was a dramatic decrease in the expression of synaptophysin in IR-treated mice. The mice were subjected to 0.5 μg/kg CART 55-102 by caudal vein injection within 15 min after the onset of reperfusion effectively increased the expression of synaptophysin ( Fig. 2C ).
CART enhanced the Arc levels in OGD cortical neurons
The Activity-regulated cytoskeleton-associated protein (Arc) is thought to be a major gene involved in synaptic remodeling in ischemic cerebral injury (Carmichael, 2006) . The study next addressed whether the neuroprotection of various concentrations CART 55-102 (0.2, 0.4, and 0.8 nM) on OGD is related to the expression of Arc. The mRNA levels of Arc were assessed. The results indicated that CART 55-102 increased Arc at the mRNA level. The abovementioned effects of CART 55-102 were in a dose-dependent manner and most significant at 0.4 nM. OGD reduced the expression of Arc mRNA by 61.16% compared with the normal control group, but showed a 22% elevation of Arc after exposure to CART 55-102 (0.4 nM; p<0.05, Fig. 3A) .
To further verify the relationship between the expression of Arc and CART 55-102 in OGD neurons, the protein levels of Arc were assessed. The result showed that the expression of Arc was reduced after OGD, but increased after exposure to various concentrations CART 55-102 (0.2, 0.4, and 0.8 nM) ( Fig. 3B ). Significant differences in Arc expression were detected between the CART group and the OGD and control groups in a dose-dependent manner. The abovementioned effects of CART 55-102 were also most significant at 0.4 nM (p<0.05) ( Fig. 3C.) .
CART up-regulated p-CREB levels in OGD cortical neurons
Activated cAMP response element binding protein (CREB) is a key factor in the regulation of Arc transcription (Kawashima et al., 2009) . The next study results demonstrated that the expression of p-CREB was apparently downregulated in the OGD group. Significant differences in the expression of p-CREB were visible between the OGD and normal groups (p< 0.01); however, the expression of p-CREB was upregulated after treatment with 0.4 nM CART 55-102 in the CART group ( Fig. 4A  and 4B ). Significant differences in the expression of p-CREB were observed between the CART group and the OGD and control groups (p< 0.01). Total CREB expression was not changed in this process. These results suggested that CART 55-102 reversed the J o u r n a l P r e -p r o o f reduced expression of p-CREB after OGD.
KG-501 inhibited expression of Arc and neurite and synapse structure in OGD cortical neurons
KG-501 is a specific inhibitor of CREB. We further found that the expression of the p-CREB, Arc and synaptophysin protein was significantly down-regulated in the KG-501 alone and KG-501-treated CART group, when compared with the CART group ( Fig. 5A-C) . Immunofluorescence double staining with a MAP2-specific antibody and a synaptophysin-specific antibody revealed that the growth of the axons and dendrites in the neurons of the KG-501-treated CART group was also significantly inhibited, and synaptophysin was also reduced. This suggests that CART may protect synaptic structure and regulate synaptic plasticity by up-regulating Arc expression of OGD neurons through the activation of CREB ( Fig. 5D ).
Discussion
CART is a neuropeptide expressed in the central nervous system and the neuroendocrine tissues discovered in 1995 (Douglass et al., 1995) . The CART peptide contains multiple fragments such as CART 10-89 , CART 85-102 , CART 55-102 , CART 62-102 , and CART 89-103 ; among them, CART 55-102 is widely expressed in cerebral tissue (Dominguez, 2006) ; in the brain, the hypothalamus has the highest CART expression, followed by the midbrain, thalamus, hindbrain, hippocampus, ventral striatum and cerebral cortex (Ahmadian-Moghadam et al., 2018) . CART 55-102 is involved in a variety of brain functions, including participation in food intake, energy regulation, inhibition of drug addiction and withdrawal, anti-anxiety, neuroendocrine regulation, stress response, and neuronal growth Mao et al., 2012; Salinas et al., 2014; Upadhya et al., 2011) . Xu et al. found that CART expression was decreased after cerebral ischemia in MCAO rats, and estrogen exerted protective effects on ischemic neurons by up-regulating CART expression (Xu et al., 2006) . The upstream signal, receptor and interaction mechanisms of CART are not yet clear. Our previous studies have found that CART inhibits oxidative stress in OGD neurons by up-regulating mitochondrial respiratory chain complex II activity, suggesting that CART has a clear protective role on local ischemic nerve cells (Sha et al., 2014) . The mechanism of CART in the promotion of the recovery of neurological function after ischemic cerebral injury still remains unclear.
Ischemic stroke is a common clinical neurological disease. Brain tissue is extremely sensitive to hypoxia, and the pathological mechanisms of ischemic stroke on neuronal damage is complex. Remodeling of synaptic function plays an important role in ischemic injury and repair, and it is closely related to functional recovery after ischemic stroke (Hofmeijer and van Putten, 2012; Murphy and Corbett, 2009 ). The effects of ischemic cerebral injury on synaptic plasticity are mainly related to changes in the structure, number, and transmission function and connection strength of the synapses (Hara, 2015; Sandvig et al., 2018) . A study found that the expression of J o u r n a l P r e -p r o o f synaptophysin (syn) was significantly changed during cerebral I/R, and that the apical dendrites of hippocampal neurons were significantly reduced on the second day post ischemia (Ishimaru et al., 2001) . Animal studies have shown that the concentrations of growth-related proteins and synaptic vesicle proteins for synaptogenesis in the dendritic spines were increased hours after a transient ischemia to restore normal synaptic structures (Hermann and Chopp, 2012) . Additionally, ischemic injury stimulated the expression of cortical synaptophysin (syp) around the ischemic foci and promoted the sprouting of new axons and the formation of new synapses post cerebral ischemia. A rehabilitation study on ischemic stroke found that post-stroke exercise up-regulated the expression of synapse-associated proteins such as growth-associated protein (GAP-43), brain-derived neurotrophic factor (BDNF), and insulin-like growth factor (IGF-1), induced continuous enhancement of long-term potentiation (LTP), regulated synaptic plasticity (Kim et al., 2015; Murphy and Corbett, 2009; Nie and Yang, 2017; Ploughman et al., 2007) , and promoted neurological recovery. Our study found that the growth of axons and dendrites in neurons was significantly inhibited after the OGD treatment, and that synaptophysin levels decreased, thus affecting synapse formation. CART treatment increased the synaptophysin levels, reversed the inhibitory effect of OGD on neuronal synaptic growth, and improved the survival rate of the OGD neurons. These results suggested that CART can effectively alleviate the damage on neuronal growth and synapses caused by OGD in vitro. In the mouse model of I/R, transmission electron microscopy results showed that the synaptic structure of neurons from cortical sections of I/R mice was damaged, the number of presynaptic vesicles in ischemic cortical neurons was decreased, the postsynaptic density (PSD) was decreased, and the width of the synaptic gap was increased. After CART treatment, the PSD and the number of presynaptic vesicles were both increased. These results suggested that ischemic injury damages the synaptic structure, while CART treatment can attenuate the effect of oxygen-glucose deprivation and the synaptic damage caused by I/R. Neuronal cell death is not an isolated process, implicating a full response from various brain cells. Neurons are connected to each other forming an extensive communication network through synaptic transmission. Failure in the synaptic process causes disconnection and transsynaptic degeneration, leading to neuronal dysfunction and cell death to neurons that are in related cerebral structures (Deleglise et al., 2018) .Our results indicated that CART may play a protective role against ischemic cerebral injury by protecting the synaptic structure and regulating synaptic plasticity. The mechanism by which CART regulates synaptic plasticity in ischemic cerebral injury has not been reported. Brain damage caused by focal cerebral ischemia involves complex changes in gene expression in cell death, tissue remodeling, and repair (Nikolaienko et al., 2018) . Ischemic injury causes neuronal depolarization and neurotransmitter release, and rapidly induces the activation of immediate early genes (IEGs) (Johansson et al., 2000; Rickhag et al., 2007) . IEGs are the first group of genes expressed following external stimulation of cells, and couple short-term extracellular signals and long-term changes in cell function. They not only participate in the normal growth and differentiation of cells, but are also involved in the process of intracellular J o u r n a l P r e -p r o o f information transmission and energy metabolism and regulate synaptic function in a variety of ways (Fukuchi and Tsuda, 2017; Kim et al., 2018) . The activation of IEGs post ischemic cerebral injury mainly occurs in the ischemic area (Sharp et al., 2000) . Effective IEGs include growth factors, metabolic and signaling enzymes, and structural proteins that can modify synaptic function in different ways. The synaptic plasticity-related IEGs in the ischemic cortex include Homer1α, Arc, early growth response transcription factor gene (Egr1/Zif268), Neuritin, and BDNF (Johansson et al., 2000; Rickhag et al., 2007) . Among them, Arc is an effector protein IEG with a fundamental role and is also a key gene in synaptic plasticity and axonal growth (Ferreri et al., 2010; Mabb and Ehlers, 2018) . Rickhag et al. reported that early expression of Arc mRNA was found within the first 24 hours of ischemia recovery (Rickhag et al., 2006) . In addition, animal studies showed that the expression of the Arc mRNA was significantly up-regulated within 12 hours after I/R in the peri-infarct cortex of rats, and then gradually decreased. Further studies of synaptic plasticity in ischemic cerebral injury have confirmed that Arc is a major gene involved in activity-dependent synaptic remodeling (Carmichael, 2006) . Our study found that the mRNA and protein expression of Arc in oxygen deprived neurons was down-regulated, and CART treatment significantly up-regulated the gene and protein expression of Arc in OGD neurons (p< 0.05). These results suggested that CART may alter the synaptic structure in specific regions of ischemia by up-regulating the expression of Arc, promoting post-ischemic synaptic remodeling, and promoting the recovery of cortical function around the injury.
Arc is an IEG associated with synapse-specific expression, and is expressed in glutamatergic neurons. It encodes for the cytoskeleton-related proteins in the PSD of glutamatergic neurons and plays an important role in the maintenance of synaptic LTP, synaptic plasticity and axonal growth. The mechanism of regulation of Arc expression is complex. Multiple signaling pathways can regulate the transcription of Arc, including the NMDA receptor, BDNF, adrenaline and acetylcholine, second messenger (Ca 2+ and cAMP), protein kinase A (PKA), Protein kinase C (PKC), extracellular signal-regulated kinase (ERK), etc. (Korb and Finkbeiner, 2011) . CREB has a specific binding site on the synaptic activity response element (SARE), a unique activity sensing element of the Arc promoter, making CREB a key factor in the regulation of the Arc promoter (Kawashima et al., 2009) . Activated CREB binds to the corresponding site of SARE and regulates Arc transcription, mediating the information transmission of presynaptic and postsynaptic membranes and the changes in synaptic plasticity (Josselyn and Nguyen, 2005; Lonze et al., 2002) . Somalwar et al. (Somalwar et al., 2018) reported that CART can induce reward behavior through phosphorylation of the PKA/ERK/CREB pathway. Our further in-depth study found that CART significantly up-regulated the expression of p-CREB in OGD neurons. However, the up-regulation of Arc expression in OGD neurons and the protection of the synaptic structure by CART can be inhibited by the CREB-specific inhibitor KG-501. CREB is necessary for the growth, proliferation, differentiation and survival of all cells. In the brain, CREB and signal system that mediated by cAMP responsive J o u r n a l P r e -p r o o f elements are involved in memory, learning, synaptic transmission, survival and differentiation of neurons and axon growth. The present data indicate that CREB also plays a role in the plastic remapping of cortical representations after stroke (Caracciolo et al., 2018) . In neurons，CREB can also affect the expression of various genes, such as Arc, syn, GAP, BDNF, etc., which can directly regulate the structure and function of synapses. These findings suggested that the protective effect of CART on the synaptic structure of OGD neurons may be achieved by activating CREB to further up-regulate Arc expression. Taken together, CART is effective in the prevention of neurons from being injured by ischemic stroke, which protects synaptic structures through activation of CREB and upregulation of Arc expression. These findings contribute to our understanding of the effects of CART on ischemic cerebral injury, and point to a role for CART and its targets as a neuroprotective agent in stroke.
Materials and Methods
Materials
CART 55-102 was purchased from Phoenix Pharmaceuticals (Belmont, California, USA). Antibodies against Arc, Synaptophysin CREB and phosphor-CREB (phosphor S133) were from Abcam (Cambridge, MA, USA). Antibodies against GAPDH, MAP-2 and the secondary antibodies were obtained from Bioworld Biotechnology (Minneapolis, MN, USA). KG501 ([3-[(4-chlorophenyl) carbamoyl]-naphthalen-2-yl] dihydrogen phosphate) were purchased from Sigma-Aldrich (St. Louis, MO, USA). PCR primers were synthesized at Invitrogen (Frederick, MD, USA).
Primary Cell Culture
Primary cortical neurons were prepared from E15-17 C57/BL6J mice embryos as previously described (Yu et al., 2017) . Kill the pregnant female mice by cervical dislocation and then clean with ethanol. After 5 min, open the abdomen and carefully remove the uterine horns containing the embryos to a dish containing HBSS. Cerebral cortex was harvested and neurons were plated on poly-D-lysine coated dishes. Subsequently, neurons were cultured in neural basal media with B27 (Invitrogen, USA) and 25nM glutamine at 37℃ in a 5% CO 2 humidified atmosphere. The purity of neuronal cultures was more than 95%, as determined by immunocytochemical staining using an antibody against microtubule-associated protein-2 (MAP-2). After about 10 days in vitro, cells were treated with OGD with or without different dosed of CART 55-102 for the further experiments. For real-time PCR and western blot analysis, neurons were plated on 6-well plates at 4x10 6 /ml.
Oxygen-glucose deprivation
Oxygen-glucose deprivation model was applied to primary cortical neurons cell J o u r n a l P r e -p r o o f cultures as described previously (Sha et al., 2013) . In brief, the culture mediums of neurons were replaced with DMEM without glucose. Then the cells were incubated in a hypoxia chamber (Billups-Rothenberg, Del Mar, CA) with a gas mixture containing 95% N 2 and 5% CO 2 for 10 min. Valves were sealed and the chambers were incubated at 37°C for 20 min. Then cells were returned to regular medium and incubated under normal conditions for another 24 h. Control cells were cultured in normal medium and environment all the time.
Middle cerebral artery occlusion (MCAO) model
Male C57BL/6J (B6) mice (aged about 2 months, 25 ± 2 g of body weight) were obtained from the Animal Model Centre of Nanjing University. All animal experiments were performed in strict accordance with the Guide for the Animal Care and Use Committee of Nanjing University. Mice were anesthetized with an intraperitoneal injection of sodium pentobarbital (1%) at a dose of 45 mg/kg. During the surgery, mice body temperature was monitored and maintained at 37.0 °C. Transient focal cerebral ischemia was induced by occlusion of the MCA for 60 min using a 6-0 surgical monofilament nylon suture with a heat-rounded tip (Doccol Corporation, MA, USA), inserted into the internal carotid artery via an external carotid stump. The mice were subjected to the dose of 0.5 μg /kg CART 55-102 by caudal vein injection within 15 min after the onset of reperfusion. After 24 h reperfusion, the mice were sacrificed ， the brain sections were subjected to transmission electron microscopy and the brain tissue of infarct/reperfusion hemisphere were separated for western blot. Sham-operated mice were used as controls.
Cell Viability Assays
Primary cortical neurons viability was detected by the Cell Counting Kit-8/CCK-8 (Dojin Laboratories, Kumamoto, Japan) according to the manufacturer's instruction. Briefly, 10μL CCK-8 working solution was added into each well of 96-well plates and incubated at 37°C for 4 h. Then, the absorbance was measured at 450nm using a microplate reader (TECAN Trading AG, Switzerland). Three replicates or more were carried out for each of the different treatments. Cell survival rates were expressed as percentages of the value of control cells without any treatment.
Real-time PCR
Total RNA was extracted from neurons with Trizol reagents (Invitrogen) according to the manufacturer 's protocol. Reverse transcription from RNA to cDNA was performed with the PrimeScript RT regent kit (Takara, Dalian, China). Quantitative PCR was carried out in a StepOne Plus PCR system (Applies Biosystems, USA) using SYBR green kit (Takara). The primers are as follows: Arc: F: GGTAAGTGCCGAGCTGAGATG, R: CGACCTGTGCAACCCTTTC; 
Western blot
We used 150μl lysis buffer (supplemented with PMSF) to each well of 6-well plate for 30 min on ice and collected with a cell scraper. We added 500μl lysis buffer to tissue sample and grinded for 30min on ice. Then the lysates were centrifuged at 4°C for 30min. The concentration of protein was about 1.5 μg/μl and 20μl protein solution was subjected to SDS-PAGE. After separating by SDS-PAGE (10% gradient gel) and electrophoretically transferring onto a PVDF membrane (Bio-Rad), membranes were blocked with 5% skim milk for 1 h and incubated with indicated primary overnight and secondary antibodies for another 2 h. The proteins were detected with ECL Detection Kit (Millipore, Bedford, MA) and the images were taken by Gel-Pro system (Tanon Technologies, Shanghai, China) . The intensity of the blots was quantified with densitometry.
Immunofluorescence assay
Neurons were fixed with cold 4% paraformaldehyde (PFA) and then blocked with 2% BSA for 1 h at room temperature. After washing 3 times with PBS, monoclonal antibodies to MAP-2 (1:500) and Synaptophysin (1:1000) were used overnight followed by 2 h incubation with the indicated secondary antibody in the dark. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI) (Beyotime Biotechnology, China) for 15 min. The fluorescence was photographed using an Olympus BX51 microscope.
TEM analysis
Mice were perfused with 0.9% saline under deep anesthesia, followed by a mixture of 4% paraformaldehyde and 2% glutaraldehyde (n=3 per group). Perfused mice were then decapitated and the brains rapidly removed. The ischemic cortex was cut and treated as described previously (Jin et al., 2015) . The ultrastructure was observed using JEM-1010 transmission electron microscopy (TEM) (JEOL Ltd., Tokyo, Japan). Photos were taken at 5,000 to 10,000 magnification (5 photos/section; 3 sections/mouse; 3 mice/group). A synapse was defined as having both a postsynaptic density and at least two vesicles in the presynaptic density.
Statistical analysis
The experimental data were represented as mean ± SEM. Statistical analysis among groups was done by one-way ANOVA followed by Dunnett's multiple comparison test. A value of p<0.05 was considered statistically difference. 
Figure Legends
